These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 28421553)

  • 1. Microwave ablation of malignant renal tumours: intermediate-term results and usefulness of RENAL and mRENAL scores for predicting outcomes and complications.
    Ierardi AM; Puliti A; Angileri SA; Petrillo M; Duka E; Floridi C; Lecchi M; Carrafiello G
    Med Oncol; 2017 May; 34(5):97. PubMed ID: 28421553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computed tomography-guided percutaneous microwave ablation for renal cell carcinoma: evaluating the performance of nephrometry scores.
    Efthymiou E; Velonakis G; Charalampopoulos G; Mazioti A; Brountzos E; Kelekis N; Filippiadis D
    Eur Radiol; 2023 Nov; 33(11):7388-7397. PubMed ID: 37318604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Percutaneous Microwave Ablation of Histologically Proven T1 Renal Cell Carcinoma.
    Aarts BM; Prevoo W; Meier MAJ; Bex A; Beets-Tan RGH; Klompenhouwer EG; Gómez FM
    Cardiovasc Intervent Radiol; 2020 Jul; 43(7):1025-1033. PubMed ID: 32052093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microwave treatment of renal cell carcinoma adjacent to renal sinus.
    Gao Y; Liang P; Yu X; Yu J; Cheng Z; Han Z; Duan S; Huang H
    Eur J Radiol; 2016 Nov; 85(11):2083-2089. PubMed ID: 27776662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Percutaneous microwave ablation of T1a and T1b renal cell carcinoma: short-term efficacy and complications with emphasis on tumor complexity and single session treatment.
    Wells SA; Wheeler KM; Mithqal A; Patel MS; Brace CL; Schenkman NS
    Abdom Radiol (NY); 2016 Jun; 41(6):1203-11. PubMed ID: 27167230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and efficacy of RFA versus MWA for T1a renal cell carcinoma: a propensity score analysis.
    Aarts BM; Gomez FM; Lopez-Yurda M; Bevers RFM; Herndriks J; Beets-Tan RGH; Bex A; Klompenhouwer EG; van der Meer RW
    Eur Radiol; 2023 Feb; 33(2):1040-1049. PubMed ID: 36066733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Percutaneous microwave ablation of renal cancers under CT guidance: safety and efficacy with a 2-year follow-up.
    Chan P; Vélasco S; Vesselle G; Boucebci S; Herpe G; Debaene B; Ingrand P; Irani J; Tasu JP
    Clin Radiol; 2017 Sep; 72(9):786-792. PubMed ID: 28545682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contrast-enhanced ultrasound-guided percutaneous microwave ablation of renal cell carcinoma that is inconspicuous on conventional ultrasound.
    Chen CN; Liang P; Yu J; Yu XL; Cheng ZG; Han ZY; Liu FY; Li X
    Int J Hyperthermia; 2016 Sep; 32(6):607-13. PubMed ID: 27269816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy, safety and effectiveness of image-guided percutaneous microwave ablation in cystic renal lesions Bosniak III or IV after 24 months follow up.
    Carrafiello G; Dionigi G; Ierardi AM; Petrillo M; Fontana F; Floridi C; Boni L; Rovera F; Rausei S; Mangano A; Spampatti S; Marconi A; Carcano G; Dionigi R
    Int J Surg; 2013; 11 Suppl 1():S30-5. PubMed ID: 24380547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Tumor Complexity and Technique on Efficacy and Complications after Percutaneous Microwave Ablation of Stage T1a Renal Cell Carcinoma: A Single-Center, Retrospective Study.
    Klapperich ME; Abel EJ; Ziemlewicz TJ; Best S; Lubner MG; Nakada SY; Hinshaw JL; Brace CL; Lee FT; Wells SA
    Radiology; 2017 Jul; 284(1):272-280. PubMed ID: 28076721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. US-guided percutaneous microwave ablation versus open radical nephrectomy for small renal cell carcinoma: intermediate-term results.
    Yu J; Liang P; Yu XL; Cheng ZG; Han ZY; Zhang X; Dong J; Mu MJ; Li X; Wang XH
    Radiology; 2014 Mar; 270(3):880-7. PubMed ID: 24475805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. US-guided percutaneous microwave ablation of renal cell carcinoma: intermediate-term results.
    Yu J; Liang P; Yu XL; Cheng ZG; Han ZY; Mu MJ; Wang XH
    Radiology; 2012 Jun; 263(3):900-8. PubMed ID: 22495684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Introduction of Microwave Ablation Into a Renal Ablation Practice: Valuable Lessons Learned.
    Thompson SM; Schmitz JJ; Thompson RH; Weisbrod AJ; Welch BT; Viers BR; Hannon JD; Schmit GD; Atwell TD; Kurup AN
    AJR Am J Roentgenol; 2018 Dec; 211(6):1381-1389. PubMed ID: 30247980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-Term Clinical Outcomes Following Radiofrequency and Microwave Ablation of Renal Cell Carcinoma at a Single VA Medical Center.
    Abboud SE; Patel T; Soriano S; Giesler J; Alvarado N; Kang P
    Curr Probl Diagn Radiol; 2018; 47(2):98-102. PubMed ID: 28648469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-antenna microwave ablation under contrast-enhanced ultrasound guidance for treatment of small renal cell carcinoma: preliminary experience.
    Carrafiello G; Mangini M; Fontana F; Recaldini C; Piacentino F; Pellegrino C; Laganà D; Cuffari S; Marconi A; Fugazzola C
    Cardiovasc Intervent Radiol; 2010 Apr; 33(2):367-74. PubMed ID: 19915901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term oncologic outcomes after radiofrequency ablation for T1 renal cell carcinoma.
    Psutka SP; Feldman AS; McDougal WS; McGovern FJ; Mueller P; Gervais DA
    Eur Urol; 2013 Mar; 63(3):486-92. PubMed ID: 22959191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Percutaneous microwave ablation therapy of renal cancer local relapse after radical nephrectomy: a feasibility and efficacy study.
    Ierardi AM; Carnevale A; Rossi UG; Renzulli M; Garanzini E; Golfieri R; Macchione N; Cittanti C; Giganti M; Carrafiello G
    Med Oncol; 2020 Mar; 37(4):27. PubMed ID: 32166412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Percutaneous Microwave Ablation Versus Cryoablation in the Treatment of T1a Renal Tumors.
    De Cobelli F; Papa M; Panzeri M; Colombo M; Steidler S; Ambrosi A; Cao R; Gusmini S; Marra P; Capitanio U; Bertini R; Venturini M; Losa A; Gaboardi F; Montorsi F; Cardone G
    Cardiovasc Intervent Radiol; 2020 Jan; 43(1):76-83. PubMed ID: 31451888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor location does not impact oncologic outcomes for percutaneous microwave ablation of clinical T1a renal cell carcinoma.
    Maciolek KA; Abel EJ; Posielski NM; Hinshaw JL; Lubner MG; Lee FT; Ziemlewicz TJ; Wells SA
    Eur Radiol; 2019 Nov; 29(11):6319-6329. PubMed ID: 31016448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Percutaneous cryoablation of solitary sporadic renal cell carcinomas.
    Schmit GD; Thompson RH; Kurup AN; Weisbrod AJ; Carter RE; Callstrom MR; Atwell TD
    BJU Int; 2012 Dec; 110(11 Pt B):E526-31. PubMed ID: 22584010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.